Clinical Trial

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-11-06; most recent amendment 2026-07-20.
Trial Details
NCT Number NCT07226258
Lead Sponsor Saol Therapeutics Inc
Conditions Osteoarthritis Knee Pain
Enrollment 150 participants
Start Date 2025-11-07
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-21